The initial purpose of this research was first to assess the role of PD-L1 expressed on tumor cells on NK cell function and second to determine the impact of PD-L1/PD-1 interaction in NK cell-mediated mechanisms of rejection. The gene discussed is CD274; the disease is neoplasm.